LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
(Adnkronos) – ANDERNACH, Germany, June 8, 2023 /PRNewswire/ — LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”),
